Literature DB >> 21798256

Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells.

Amy K McNally1, James M Anderson.   

Abstract

Foreign body-type multinucleated giant cells (FBGC), formed by macrophage fusion, are a prominent cell type on implanted biomaterials, although the roles they play at these and other sites of chronic inflammation are not understood. Why lymphocytes are present in this scenario and the effects of fusing macrophages/FBGC on subsequent lymphocyte responses are also unclear. To address the physiological significance of FBGC in this regard, we employed our in vitro system of interleukin (IL)-4-induced human monocyte-derived macrophage fusion/FBGC formation. Initially, we pursued the identities of lymphocyte co-stimulatory molecules on fusing macrophages/FBGC. In addition, we further compared the FBGC phenotype to that currently associated with osteoclasts and dendritic cells using recognized markers. Immunoblotting of cell lysates and immunochemistry of macrophages/FBGC in situ, revealed that IL-4-induced macrophages/FBGC strongly express HLA-DR, CD98, B7-2 (CD86), and B7-H1 (PD-L1), but not B7-1 (CD80) or B7-H2 (B7RP-1). Furthermore, molecules currently recognized to be expressed on osteoclasts (calcitonin receptor, tartrate-resistant acid phosphatase, RANK) or dendritic cells (CD1a, CD40, CD83, CD95/fas) are undetectable. In contrast, fusing macrophages/FBGC strongly express the macrophage markers αX integrin (CD11c), CD68, and dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN), whereas CD14 is completely down-modulated with IL-4-induced macrophage fusion. These novel data demonstrate that IL-4-induction of macrophage multinucleation/FBGC formation features the acquisition of a CD14-negative phenotypic profile which is distinguishable from that of dendritic cells and osteoclasts, yet potentially exhibits multiple capacities for lymphocyte interactions with resultant lymphocyte down-modulation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798256      PMCID: PMC3220734          DOI: 10.1016/j.yexmp.2011.06.012

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  41 in total

1.  Induction of CD40 ligand expression in human T cells by biomaterials derived from left ventricular assist device surface.

Authors:  M Schuster; A Kocher; K Lietz; J Ankersmit; R John; N Edwards; M Oz; S Itescu
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

Review 2.  Multinucleated giant cells.

Authors:  J M Anderson
Journal:  Curr Opin Hematol       Date:  2000-01       Impact factor: 3.284

Review 3.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 4.  CD83 on dendritic cells: more than just a marker for maturation.

Authors:  Matthias Lechmann; Susanne Berchtold; Joachim Hauber; Alexander Steinkasserer
Journal:  Trends Immunol       Date:  2002-06       Impact factor: 16.687

5.  Physical association and functional interaction between beta1 integrin and CD98 on human T lymphocytes.

Authors:  Yuko J Miyamoto; Jason S Mitchell; Bradley W McIntyre
Journal:  Mol Immunol       Date:  2003-01       Impact factor: 4.407

Review 6.  Biocompatibility of implants: lymphocyte/macrophage interactions.

Authors:  James M Anderson; Amy K McNally
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

Review 7.  The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.

Authors:  Beatriz M Carreno; Mary Collins
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 8.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

9.  Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses.

Authors:  Dimitrios Tzachanis; Alla Berezovskaya; Lee M Nadler; Vassiliki A Boussiotis
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

10.  Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation.

Authors:  Amy K McNally; James M Anderson
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

View more
  12 in total

1.  Cutting edge: microRNA regulation of macrophage fusion into multinucleated giant cells.

Authors:  James R Sissons; Jacques J Peschon; Frank Schmitz; Rosa Suen; Mark Gilchrist; Alan Aderem
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

Review 2.  A microglial hypothesis of globoid cell leukodystrophy pathology.

Authors:  Alexandra M Nicaise; Ernesto R Bongarzone; Stephen J Crocker
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: dependence on material surface properties.

Authors:  Amy K McNally; James M Anderson
Journal:  J Biomed Mater Res A       Date:  2014-07-26       Impact factor: 4.396

Review 4.  Macrophage and Fibroblast Interactions in Biomaterial-Mediated Fibrosis.

Authors:  Claire E Witherel; Daniel Abebayehu; Thomas H Barker; Kara L Spiller
Journal:  Adv Healthc Mater       Date:  2019-01-18       Impact factor: 9.933

5.  Multinucleated giant cell phenotype in response to stimulation.

Authors:  Kevin L Trout; Andrij Holian
Journal:  Immunobiology       Date:  2020-05-05       Impact factor: 3.144

Review 6.  Localized AL amyloidosis: a suicidal neoplasm?

Authors:  Per Westermark
Journal:  Ups J Med Sci       Date:  2012-02-15       Impact factor: 2.384

7.  Induction of multinucleated giant cells in response to small sized bovine bone substitute (Bio-Oss™) results in an enhanced early implantation bed vascularization.

Authors:  M Barbeck; S E Udeabor; J Lorenz; A Kubesch; J Choukroun; R A Sader; C J Kirkpatrick; S Ghanaati
Journal:  Ann Maxillofac Surg       Date:  2014 Jul-Dec

8.  Bone Immune Response to Materials, Part II: Copper and Polyetheretherketone (PEEK) Compared to Titanium at 10 and 28 Days in Rabbit Tibia.

Authors:  Ricardo Trindade; Tomas Albrektsson; Silvia Galli; Zdenka Prgomet; Pentti Tengvall; Ann Wennerberg
Journal:  J Clin Med       Date:  2019-06-07       Impact factor: 4.241

9.  IL-10 modulates in vitro multinucleate giant cell formation in human tuberculosis.

Authors:  Parul Shrivastava; Tamishraha Bagchi
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

10.  Regulation and Biological Significance of Formation of Osteoclasts and Foreign Body Giant Cells in an Extraskeletal Implantation Model.

Authors:  Gazi Jased Ahmed; Eri Tatsukawa; Kota Morishita; Yasuaki Shibata; Fumio Suehiro; Masanobu Kamitakahara; Taishi Yokoi; Takehiko Koji; Masahiro Umeda; Masahiro Nishimura; Tohru Ikeda
Journal:  Acta Histochem Cytochem       Date:  2016-06-16       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.